MELBOURNE, Australia, May 31, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will.
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer